CIZ1 and neoplasm: Importantly, targeting cancer-specific splice variations or depletion of Ciz1 by siRNA reduced tumor growth in xenograft models, identifying a potentially selective therapeutic avenue to reduce tumor proliferation [73,74,77,78,79,80,81].